BIOMARKERS FOR PRE-DIABETES, CARDIOVASCULAR DISEASES, AND OTHER METABOLIC-SYNDROME RELATED DISORDERS AND METHODS USING THE SAME

Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	COSTEL CHIRILA, KAY LAWTON, MICHAEL MILBURN, WALTER GALL, MATTHEW W. MITCHELL, YUN FU HU, DANNY ALEXANDER
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. Se proporcionan biomarcadores relacionados con resistencia a insulina, prediabetes, diabetes tipo 2, s?ndrome metab?lico, aterosclerosis y cardiomiopat?a, as? como m?todos para utilizar los biomarcadores como biomarcadores para resistencia a insulina, prediabetes, diabetes tipo 2, s?ndrome metab?lico, aterosclerosis y cardiomiopat?a. Adem?s, tambi?n se proporcionan m?todos para modular los trastornos o condiciones respectivas de un sujeto. Tambi?n se proporcionan conjuntos de entidades de mol?culas peque?as como biomarcadores para resistencia a insulina, prediabetes, diabetes tipo 2, s?ndrome metab?lico, aterosclerosis y cardiomiopat?a.